We herein describe a 71-year-old woman with adult-onset Still's disease (AOSD) who developed fever, myalgia, and pancytopenia. The bone marrow aspiration and muscle biopsy revealed hemophagocytic syndrome (HPS) and inflammatory myopathy with abundant macrophages (IMAM). Immunostained specimens were positive for expression of retinoic acid-inducible gene-I (RIG-I), which recognizes viral RNA in infiltrated mononuclear cells as well as muscle tissues. These findings suggest that RIG-I may be involved in induction of HPS and IMAM in AOSD.
Introduction
Hemophagocytic syndrome (HPS), also known as macrophage activation syndrome (MAS), sometimes develops in patients with adult-onset Still's disease (AOSD) (1, 2) . MAS is thought to be caused by the uncontrolled activation and proliferation of T lymphocytes and macrophages that can develop as a primary condition or secondary to malignancy, infections, autoimmune diseases and pharmacotherapy resulting in fever, splenomegaly, pancytopenia, and disseminated intravascular coagulation (DIC).
Inflammatory myopathy with abundant macrophages (IMAM) has been proposed as one spectrum of inflammatory myopathy (3) (4) (5) (6) . IMAM is mainly detected among patients with a dermatomyositis (DM)-like disease; infiltration of macrophages is diffuse and positively correlates with both T cell infiltrates and acute muscle fiber damage.
The complication of HPS and IMAM in patients with AOSD is rare. We herein describe a patient with AOSD who presented with HPS and IMAM and suggest the existence of a relationship between these serious complications. Table) revealed: white blood cell count 5,400/μL (73.0% neutrophils, 18.0% lymphocytes), hemoglobin 9.4 g/dL, platelet count 114,000/μL, erythrocyte sedimentation rate (ESR) of 71 mm/hr, and C-reactive protein (CRP) 2.38 mg/dL. The aspartate aminotransferase (AST) was 50 IU/L, alanine aminotransferase (ALT) was 31 IU/L, and lactate dehydrogenase was 529 IU/L. The ferritin and soluble IL-2 receptor levels were elevated to 2,634 ng/mL and 1,781 U/mL, respectively. Although the rheumatoid factor was positive, the antinuclear antibodies (ANA) level was negative. The hepatitis B virus (HBV)-DNA polymerase chain reaction (PCR) also came back negative, although the hepatitis B antigen and hepatitis B core antibody were positive. Other viral markers of primary infection for hepatitis C, human T lymphocyte virus-1, Epstein-Barr virus, cytomegalovirus, parvovirus, and mumps virus were negative.
The patient was diagnosed as having AOSD based on 3 out of 4 major items on Yamaguchi's diagnostic criteria (7) including fever, arthralgia, and typical skin eruption and 3 of 4 minor items including throat pain, lymph node swelling/splenomegaly, and abnormal liver function tests (Fig. 1) . She received only non-steroidal anti-inflammatory drugs (NSAIDs). Her symptoms improved with a decline of CRP and ferritin levels two weeks following treatment, and she was thereafter successfully discharged.
One week later, the patient was readmitted to our hospital with the chief complaints of common cold-like symptoms such as throat pain, myalgia of bilateral lower extremities, general malaise, and a fever up to 38 . Thereafter, she also recognized skin eruption in her left ear just after taking NSAIDs. During the second admission, the laboratory findings demonstrated severe pancytopenia (leukocyte count 2,100/μL, hemoglobin 9.3 g/dL, platelet count 67,000/μL) with an elevated concentration of ferritin (24,337 ng/mL) and aldolase (31.2 IU/L). The serum concentrations of interleukin-18 (IL-18) and interferon-γ (IFN-γ) were extremely elevated to 229,126 pg/mL and 238.4 pg/mL, respectively. The DIC score was seven points (D dimer 88.8 μg/mL, prothrombin time (PT) international normalized ratio (INR) 1.25, fibrin/fibrinogen degradation products (FDP) 85 μg/mL, and fibrinogen 33.2 mg/dL). The aspiration biopsy of the bone marrow revealed hemophagocytosis by macrophages (Fig. 2) . Magnetic resonance imaging (MRI) of the lower extremities detected massive inflammatory changes in her thigh muscle and fascia (Fig. 3) . The muscle biopsy showed CD68-positive cell infiltration predominantly in the fascia, which suggested IMAM (Fig. 4) . Positive expression of interferon-alpha (IFN-α) and retinoic acid-inducible gene-I (RIG-I) in the cytoplasm of mononuclear cells, as well as muscle tissues, was also seen. The patient was diagnosed with HPS and IMAM complicated with AOSD and successfully treated with methylprednisolone pulse therapy (500 mg/day, 3 days) twice followed by oral prednisolone (30 mg/day). Her clinical symptoms and laboratory data following treatment were stable. No recurrence of HPS, IMAM, or AOSD was seen, even though the prednisolone was tapered to 10 mg/day.
Discussion
HPS is associated with infections, malignant lymphomas, autoimmune diseases, and various drugs (6, 8) . Systemic lupus erythematosus (SLE) and AOSD are known underlying autoimmune diseases of HPS (2) . Although it has been reported that 12% of AOSD patients are complicated with HPS, it is difficult to distinguish an occurrence of HPS from the flare of AOSD (9) . Leukocytosis is seen in flare-up cases of AOSD, whereas pancytopenia progresses in cases with complication of HPS. In addition, it is important to detect phagocytosis by activated macrophages in bone marrow aspirations. As AOSD patients with HPS have higher disease severity and are complicated with severe conditions, such as acute respiratory distress syndrome (ARDS), DIC, and multiple organ damage, it is important that patients be treated immediately with appropriate immunosuppressive therapy.
IMAM has been proposed as an independent disease characterized by a massive infiltration of CD68-positive macrophages in the fascia of dermatomyositis or SLE (4). Proximal muscle weakness develops with elevation of serum creatine kinase (CK) (3). The characteristic features of the MRI were hypertrophy and high intensity of the fascia, as well as muscle, on the short T1 inversion recovery (STIR) (3) . IMAM often coexists with a fatal condition, such as ARDS or HPS. Although it was previously reported that infiltrated macrophages showed hemophagocytosis in 21 of 27 IMAM patients (4), we detected hemophagocytosis in the bone marrow aspiration not in the specimens of the muscle and the fascia. Therefore, it is important to carefully monitor the occurrence of these diseases.
In our patient, HPS and IMAM, which are also referred to as MAS, developed during the follow-up course of AOSD. It is known that serum concentration of IL-18 can be elevated in AOSD patients complicated with MAS (10). In our patient, the serum concentration of IL-18 was also extremely high. Although MAS may develop in AOSD patients spontaneously, various bacterial or viral infections and drugs have been reported to be the cause of this syndrome (9) . NSAIDs are known to be capable of triggering MAS in systemic juvenile rheumatoid arthritis (11) . As NSAIDs-related MAS could not be distinguished from viralinduced MAS symptomatically, NSAIDs could therefore not be completely ruled out as the possible trigger of MAS in this patient. Among the infections, virus infections such as influenza virus, Epstein-Barr virus, and cytomegalovirus may be associated with the occurrence of MAS (2) . Although we did not detect these viral markers, immunohistological staining demonstrated positive expression of IFN-α and RIG-I in the infiltrated mononuclear cells and the muscle tissues. The positive expression of IFN-α and RIG-I was also seen in the mononuclear cells that infiltrated the fascia.
RIG-I is one of the RNA helicases that exist in the cyto- (13) and reported that RIG-I expression in human mesangial cells was involved in the inflammation in lupus nephritis (14) . In our case, the common cold-like symptoms suggesting a viral infection preceded the onset of both HPS and IMAM, and RIG-I was expressed in the cytoplasm of mononuclear cells infiltrated in the muscle tissues and the fascia. These findings suggest that excessive innate immunity responses to viral infection through IFN-α expression may therefore be induced in patients with AOSD.
In conclusion, we experienced a rare case of HPS and IMAM in a patient with AOSD who was successfully treated with methylprednisolone pulse therapy. From our findings, antiviral RIG-I signaling may therefore be involved in the initiation of HPS and IMAM.
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